Atea Pharmaceuticals, Inc. AVIR
NASDAQ · United States · Health Technology
$5.13+0.03 (+0.59%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.41 | -0.56 | +26.1% | $0 | — | +0.4%$5.05→$5.07 |
| Q1 2026 | 2026-05-12 | -0.57 | -0.60 | +5.0% | — | — | -15.5%$5.41→$4.57 |
| Q4 2025 | 2026-03-05 | -0.57 | -0.48 | -18.7% | — | — | +18.3%$4.98→$5.89 |
| Q3 2025 | 2025-11-12 | -0.53 | -0.46 | -15.2% | — | — | -9.5%$3.38→$3.06 |
| Q4 2024 | 2025-03-06 | -0.40 | -0.29 | -37.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.